US Stock MarketDetailed Quotes

FOLD Amicus Therapeutics

Watchlist
  • 8.690
  • -0.315-3.50%
Close Mar 24 16:00 ET
  • 8.980
  • +0.290+3.34%
Post 20:01 ET
2.67BMarket Cap-48.28P/E (TTM)

Amicus Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
32.29%528.3M
30.09%149.71M
36.73%141.52M
34.04%126.67M
27.97%110.4M
21.30%399.36M
30.63%115.08M
26.70%103.5M
17.06%94.5M
9.60%86.27M
Operating revenue
32.29%528.3M
30.09%149.71M
36.73%141.52M
34.04%126.67M
27.97%110.4M
21.30%399.36M
30.63%115.08M
26.70%103.5M
17.06%94.5M
9.60%86.27M
Cost of revenue
41.84%52.94M
31.01%14.84M
33.51%13.28M
23.56%11.26M
95.43%13.57M
-3.30%37.33M
20.67%11.32M
-25.97%9.95M
11.19%9.11M
-8.44%6.94M
Gross profit
31.30%475.35M
29.99%134.87M
37.07%128.24M
35.16%115.41M
22.07%96.84M
24.57%362.03M
31.82%103.76M
37.07%93.56M
17.72%85.39M
11.52%79.33M
Operating expense
1.32%441.29M
10.66%118.9M
-4.74%103.44M
-2.27%100.44M
1.54%118.51M
-12.03%435.52M
-10.05%107.45M
6.95%108.58M
-22.74%102.78M
-17.25%116.71M
Selling and administrative expenses
17.48%323.38M
23.39%86.67M
14.40%75.11M
12.46%73.58M
19.03%88.03M
29.21%275.27M
29.42%70.24M
38.88%65.65M
22.56%65.42M
27.26%73.96M
Research and development costs
-28.23%109.36M
-13.81%30.19M
-35.73%26.16M
-29.78%24.68M
-31.74%28.33M
-44.92%152.38M
-45.16%35.03M
-23.16%40.7M
-55.12%35.15M
-49.09%41.5M
Depreciation amortization depletion
8.56%8.55M
-6.46%2.04M
-2.60%2.17M
-1.09%2.18M
71.36%2.15M
47.38%7.87M
66.44%2.18M
73.25%2.23M
65.37%2.21M
-10.91%1.26M
-Depreciation and amortization
8.56%8.55M
-6.46%2.04M
-2.60%2.17M
-1.09%2.18M
71.36%2.15M
47.38%7.87M
66.44%2.18M
73.25%2.23M
65.37%2.21M
-10.91%1.26M
Operating profit
146.35%34.06M
532.58%15.97M
265.04%24.8M
186.07%14.97M
42.02%-21.68M
64.05%-73.49M
90.94%-3.69M
54.83%-15.03M
71.26%-17.39M
46.52%-37.39M
Net non-operating interest income expense
-2.60%-44.19M
5.50%-10.54M
-0.83%-11.61M
-3.60%-11.14M
-12.97%-10.9M
-26.33%-43.07M
-22.28%-11.16M
-27.14%-11.52M
-36.12%-10.76M
-20.35%-9.65M
Non-operating interest income
-23.61%5.41M
-15.26%1.42M
-26.51%1.08M
-21.13%1.37M
-29.97%1.54M
134.06%7.08M
-15.26%1.67M
161.28%1.47M
387.92%1.74M
1,553.38%2.2M
Non-operating interest expense
-1.10%49.6M
-6.77%11.96M
-2.26%12.69M
0.16%12.51M
5.00%12.44M
35.10%50.15M
15.61%12.83M
34.99%12.99M
51.29%12.49M
45.38%11.84M
Other net income (expense)
44.45%-18.63M
114.90%2.51M
-448.53%-6.41M
69.96%-3.72M
-77.91%-11.01M
-853.27%-33.54M
16.82%-16.81M
-85.93%1.84M
-272.98%-12.37M
-75.52%-6.19M
Special income (charges)
47.94%-9.19M
--0
-57.54%-3.14M
--0
-2,308.37%-6.05M
-129.40%-17.65M
-779.61%-13.93M
-251.85%-2M
-1,179.13%-1.47M
95.38%-251K
-Less:Restructuring and merger&acquisition
255.71%9.19M
--0
57.54%3.14M
--0
2,308.37%6.05M
139.61%2.58M
--0
251.85%2M
193.04%337K
121.13%251K
-Less:Other special charges
----
----
----
----
----
--13.93M
----
----
----
----
-Write off
--0
--0
--0
--0
----
-82.86%1.13M
--0
--0
--1.13M
----
Other non- operating income (expenses)
40.57%-9.44M
187.01%2.51M
-185.13%-3.26M
65.91%-3.72M
16.37%-4.97M
-480.41%-15.89M
84.54%-2.88M
-71.89%3.83M
-250.00%-10.9M
-412.20%-5.94M
Income before tax
80.84%-28.76M
125.06%7.93M
127.46%6.79M
100.27%108K
18.11%-43.58M
37.98%-150.1M
54.82%-31.66M
15.58%-24.71M
33.85%-40.52M
34.66%-53.22M
Income tax
1,744.23%27.35M
-411.73%-6.81M
532.03%13.51M
482.14%15.81M
1,785.02%4.84M
127.11%1.48M
115.36%2.18M
-177.75%-3.13M
198.02%2.72M
-107.53%-287K
Net income
62.99%-56.11M
143.55%14.74M
68.81%-6.73M
63.69%-15.7M
8.53%-48.42M
35.92%-151.58M
39.42%-33.84M
35.18%-21.58M
30.45%-43.23M
37.92%-52.93M
Net income continuous Operations
62.99%-56.11M
143.55%14.74M
68.81%-6.73M
63.69%-15.7M
8.53%-48.42M
35.92%-151.58M
39.42%-33.84M
35.18%-21.58M
30.45%-43.23M
37.92%-52.93M
Minority interest income
Net income attributable to the parent company
62.99%-56.11M
143.55%14.74M
68.81%-6.73M
63.69%-15.7M
8.53%-48.42M
35.92%-151.58M
39.42%-33.84M
35.18%-21.58M
30.45%-43.23M
37.92%-52.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
62.99%-56.11M
143.55%14.74M
68.81%-6.73M
63.69%-15.7M
8.53%-48.42M
35.92%-151.58M
39.42%-33.84M
35.18%-21.58M
30.45%-43.23M
37.92%-52.93M
Basic earnings per share
64.71%-0.18
145.45%0.05
71.43%-0.02
66.67%-0.05
11.11%-0.16
37.80%-0.51
42.11%-0.11
41.67%-0.07
28.57%-0.15
40.00%-0.18
Diluted earnings per share
64.71%-0.18
145.45%0.05
71.43%-0.02
66.67%-0.05
11.11%-0.16
37.80%-0.51
42.11%-0.11
41.67%-0.07
28.57%-0.15
40.00%-0.18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 32.29%528.3M30.09%149.71M36.73%141.52M34.04%126.67M27.97%110.4M21.30%399.36M30.63%115.08M26.70%103.5M17.06%94.5M9.60%86.27M
Operating revenue 32.29%528.3M30.09%149.71M36.73%141.52M34.04%126.67M27.97%110.4M21.30%399.36M30.63%115.08M26.70%103.5M17.06%94.5M9.60%86.27M
Cost of revenue 41.84%52.94M31.01%14.84M33.51%13.28M23.56%11.26M95.43%13.57M-3.30%37.33M20.67%11.32M-25.97%9.95M11.19%9.11M-8.44%6.94M
Gross profit 31.30%475.35M29.99%134.87M37.07%128.24M35.16%115.41M22.07%96.84M24.57%362.03M31.82%103.76M37.07%93.56M17.72%85.39M11.52%79.33M
Operating expense 1.32%441.29M10.66%118.9M-4.74%103.44M-2.27%100.44M1.54%118.51M-12.03%435.52M-10.05%107.45M6.95%108.58M-22.74%102.78M-17.25%116.71M
Selling and administrative expenses 17.48%323.38M23.39%86.67M14.40%75.11M12.46%73.58M19.03%88.03M29.21%275.27M29.42%70.24M38.88%65.65M22.56%65.42M27.26%73.96M
Research and development costs -28.23%109.36M-13.81%30.19M-35.73%26.16M-29.78%24.68M-31.74%28.33M-44.92%152.38M-45.16%35.03M-23.16%40.7M-55.12%35.15M-49.09%41.5M
Depreciation amortization depletion 8.56%8.55M-6.46%2.04M-2.60%2.17M-1.09%2.18M71.36%2.15M47.38%7.87M66.44%2.18M73.25%2.23M65.37%2.21M-10.91%1.26M
-Depreciation and amortization 8.56%8.55M-6.46%2.04M-2.60%2.17M-1.09%2.18M71.36%2.15M47.38%7.87M66.44%2.18M73.25%2.23M65.37%2.21M-10.91%1.26M
Operating profit 146.35%34.06M532.58%15.97M265.04%24.8M186.07%14.97M42.02%-21.68M64.05%-73.49M90.94%-3.69M54.83%-15.03M71.26%-17.39M46.52%-37.39M
Net non-operating interest income expense -2.60%-44.19M5.50%-10.54M-0.83%-11.61M-3.60%-11.14M-12.97%-10.9M-26.33%-43.07M-22.28%-11.16M-27.14%-11.52M-36.12%-10.76M-20.35%-9.65M
Non-operating interest income -23.61%5.41M-15.26%1.42M-26.51%1.08M-21.13%1.37M-29.97%1.54M134.06%7.08M-15.26%1.67M161.28%1.47M387.92%1.74M1,553.38%2.2M
Non-operating interest expense -1.10%49.6M-6.77%11.96M-2.26%12.69M0.16%12.51M5.00%12.44M35.10%50.15M15.61%12.83M34.99%12.99M51.29%12.49M45.38%11.84M
Other net income (expense) 44.45%-18.63M114.90%2.51M-448.53%-6.41M69.96%-3.72M-77.91%-11.01M-853.27%-33.54M16.82%-16.81M-85.93%1.84M-272.98%-12.37M-75.52%-6.19M
Special income (charges) 47.94%-9.19M--0-57.54%-3.14M--0-2,308.37%-6.05M-129.40%-17.65M-779.61%-13.93M-251.85%-2M-1,179.13%-1.47M95.38%-251K
-Less:Restructuring and merger&acquisition 255.71%9.19M--057.54%3.14M--02,308.37%6.05M139.61%2.58M--0251.85%2M193.04%337K121.13%251K
-Less:Other special charges ----------------------13.93M----------------
-Write off --0--0--0--0-----82.86%1.13M--0--0--1.13M----
Other non- operating income (expenses) 40.57%-9.44M187.01%2.51M-185.13%-3.26M65.91%-3.72M16.37%-4.97M-480.41%-15.89M84.54%-2.88M-71.89%3.83M-250.00%-10.9M-412.20%-5.94M
Income before tax 80.84%-28.76M125.06%7.93M127.46%6.79M100.27%108K18.11%-43.58M37.98%-150.1M54.82%-31.66M15.58%-24.71M33.85%-40.52M34.66%-53.22M
Income tax 1,744.23%27.35M-411.73%-6.81M532.03%13.51M482.14%15.81M1,785.02%4.84M127.11%1.48M115.36%2.18M-177.75%-3.13M198.02%2.72M-107.53%-287K
Net income 62.99%-56.11M143.55%14.74M68.81%-6.73M63.69%-15.7M8.53%-48.42M35.92%-151.58M39.42%-33.84M35.18%-21.58M30.45%-43.23M37.92%-52.93M
Net income continuous Operations 62.99%-56.11M143.55%14.74M68.81%-6.73M63.69%-15.7M8.53%-48.42M35.92%-151.58M39.42%-33.84M35.18%-21.58M30.45%-43.23M37.92%-52.93M
Minority interest income
Net income attributable to the parent company 62.99%-56.11M143.55%14.74M68.81%-6.73M63.69%-15.7M8.53%-48.42M35.92%-151.58M39.42%-33.84M35.18%-21.58M30.45%-43.23M37.92%-52.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 62.99%-56.11M143.55%14.74M68.81%-6.73M63.69%-15.7M8.53%-48.42M35.92%-151.58M39.42%-33.84M35.18%-21.58M30.45%-43.23M37.92%-52.93M
Basic earnings per share 64.71%-0.18145.45%0.0571.43%-0.0266.67%-0.0511.11%-0.1637.80%-0.5142.11%-0.1141.67%-0.0728.57%-0.1540.00%-0.18
Diluted earnings per share 64.71%-0.18145.45%0.0571.43%-0.0266.67%-0.0511.11%-0.1637.80%-0.5142.11%-0.1141.67%-0.0728.57%-0.1540.00%-0.18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More